BIOFRONTERA INC (BFRI)
NASDAQHealth CareMedical - PharmaceuticalsSnapshot 2026-09-04
$1.61+6.62%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - PharmaceuticalsSnapshot 2026-09-04
QuarterlyIQ Insights · BFRI
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 46.2 | 41.7 | 37.3 | 34.1 | 28.7 | 24.1 | 18.8 |
| Total Revenues | — | — | — | — | 28.7 | 24.1 | — |
| Operating Expenses & Income | |||||||
| Selling, General & Admin | 39.2 | 37.8 | — | 39.0 | 35.1 | 36.5 | 17.7 |
| R&D Expenses | 3.0 | 3.7 | 2.1 | 0.1 | — | — | — |
| Operating Income | (6.6) | (11.3) | (17.2) | (22.7) | (18.6) | (25.2) | (9.6) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | — | — | 0.2 | 0.0 | 0.3 | 2.9 |
| Interest & Investment Income | — | — | 0.1 | 0.1 | — | 0.0 | 0.0 |
| Net Interest Expenses | — | — | — | 0.1 | — | 0.3 | 2.8 |
| Other Non-Operating Income / Expenses | 0.2 | 0.8 | (0.5) | 2.6 | 18.0 | (12.5) | (1.3) |
| EBT, Incl. Unusual Items | (6.3) | (10.5) | (17.7) | (20.1) | (0.6) | (37.7) | (10.9) |
| Income Tax Expense | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 |
| Net Income | |||||||
| Net Income | (6.4) | (10.5) | (17.8) | (20.1) | (0.6) | (37.7) | (11.0) |
| Per Share | |||||||
| Basic EPS | (0.49) | (1.04) | (3.22) | (13.02) | (0.61) | (85.63) | — |
| Diluted EPS | (0.49) | (1.04) | (3.22) | (13.02) | (0.61) | — | — |
| Revenue per Share | 3.57 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 12.9 | 10.2 | 5.5 | 1.5 | 1.1 | 0.4 | — |
| Diluted Weighted Avg Shares | 12.9 | 10.2 | 5.5 | 1.5 | 1.1 | — | — |
| Supplemental | |||||||
| EBITDA | — | (11.2) | (16.6) | (22.1) | — | — | — |
| EBIT | (6.6) | (11.3) | (17.2) | (22.7) | (18.6) | (25.2) | (9.6) |
| Effective Tax Rate | — | — | — | -0.1% | -5.3% | -0.1% | -0.6% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.